VCU Massey figure 8 (IMAGE)
Caption
New research led by scientists at VCU Massey Comprehensive Cancer Center suggests that a class of drugs known as MCL-1 (myeloid leukemia cell-1) inhibitors interact with a type of kinase inhibitor that targets the SRC gene to efficiently trigger cell death in acute myeloid leukemia cells.
Credit
Xiaoyan Hu et al
Usage Restrictions
This image may only be used in conjunction with reporting on this study.
License
Licensed content